Channing Capital Management, LLC Baxter International Inc Transaction History

Channing Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$37.88 - $43.77 $265,652 - $306,959	-7,013 Reduced 3.74%	180,335 $7.71 Million
Q4 2023 Feb 06, 2024	BUY	$31.71 - $38.95 $975,684 - $1.2 Million	30,769 Added 19.65%	187,348 $7.24 Million
Q3 2023 Nov 13, 2023	SELL	$37.32 - $49.29 $255,716 - $337,735	-6,852 Reduced 4.19%	156,579 $5.91 Million
Q2 2023 Aug 11, 2023	SELL	$39.98 - $47.68 $454,092 - $541,549	-11,358 Reduced 6.5%	163,431 $7.45 Million
Q1 2023 May 09, 2023	SELL	$37.58 - $52.57 $393,838 - $550,933	-10,480 Reduced 5.66%	174,789 $7.09 Million
Q4 2022 Feb 14, 2023	BUY	$49.7 - $57.71 $1.74 Million - $2.02 Million	35,062 Added 23.34%	185,269 $9.44 Million
Q3 2022 Nov 08, 2022	BUY	$53.86 - $66.8 $1.67 Million - $2.07 Million	31,061 Added 26.07%	150,207 $8.09 Million
Q2 2022 Aug 11, 2022	BUY	$63.83 - $80.0 $78,702 - $98,640	1,233 Added 1.05%	119,146 $7.65 Million
Q1 2022 May 12, 2022	BUY	$76.85 - $89.45 $9.06 Million - $10.5 Million	117,913 New	117,913 $9.14 Million
Q4 2020 Feb 11, 2021	SELL	$75.39 - $82.36 $4.6 Million - $5.03 Million	-61,035 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$78.33 - $90.73 $41,593 - $48,177	531 Added 0.88%	61,035 $4.91 Million
Q2 2020 Aug 14, 2020	SELL	$78.66 - $94.14 $441,990 - $528,972	-5,619 Reduced 8.5%	60,504 $5.21 Million
Q1 2020 May 13, 2020	BUY	$71.57 - $93.3 $344,466 - $449,052	4,813 Added 7.85%	66,123 $5.37 Million
Q4 2019 Feb 12, 2020	BUY	$76.7 - $88.45 $4.7 Million - $5.42 Million	61,310 New	61,310 $5.13 Million

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Channing Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Channing Capital Management, LLC with notifications on news.